002432 Andon Health
- 42.54
- -0.47-1.09%
Andon Health News
Andon Health's Subsidiary Gets US FDA's Nod to Market COVID-19, Influenza Test Kit
The US Food and Drug Administration granted an emergency use authorization or EUA to Chinese pharmaceutical firm Andon Health's (SHE:002432) subsidiary iHealth Labs for its triple home test kit for CO
IHealth Unveils Breakthrough 3-in-1 At-Home 15-Minute Antigen Test for COVID-19 and Flu AB
A New Era of Testing Emerges as Leading Supplier of COVID Tests Receives FDA Emergency Use Authorization for Combo COVID + Flu TestSUNNYVALE, Calif., May 8, 2024 /PRNewswire/ -- iHealth Labs, Inc. (i
Andon Health's US Unit Gets FDA Emergency Use Authorization for 3-in-1 Home Test Kits
The US Food and Drug Administration granted Andon Health's (SHE:002432) US subsidiary iHealth Labs an emergency use authorization for its triple home test kit for novel coronavirus, influenza A, and i
Express News | Dragon Tiger List | Jiu'an Medical's net purchases of the three institutions that went up and down today totaled 134 million yuan
Express News | Morning announcements
Express News | Jiu'an Medical: The US subsidiary's three joint inspection OTC products were authorized by the US FDA EUA
Express News | Yesterday, 343 A-share companies disclosed progress in implementing share repurchases. Jiu'an Medical, Pharmaceutical Kangde, and Youyou Network had the highest repurchase amounts
Jiu'an Medical (002432.SZ): 5.58% of shares have been repurchased cumulatively
Gelonghui, May 6, 丨 Jiu'an Medical (002432.SZ) announced that as of April 30, 2024, the company had repurchased a total of 27,290,540 shares through a special stock repurchase securities account, accounting for 5.58% of the company's total share capital. The highest transaction price was 41.277 yuan/share, the minimum transaction price was 39.42 yuan/share, and the total payment amount was RMB 1,102 billion (excluding transaction fees).
Express News | Jiu'an Healthcare: Net profit in the first quarter fell 58.86% year on year
50 billion! Another college science and technology innovation parent fund established Tianjin University to run out of several unicorns
① Tiankai Jiu'an Haihe Begonia Science and Technology Innovation Parent Fund was officially registered and established, with a scale of 5 billion yuan. In recent years, Tianjin University has continued to make efforts to transform scientific and technological achievements, with an annual funding of 4 billion yuan for scientific research. ② Deep Blue, Yisiwei, and Jingfeng Medical are all proposed IPOs from Tianjin University.
Jiu'an Medical (002432.SZ) has repurchased a total of 5.27% of its shares at a cost of about 1.04 billion yuan
Jiu'an Medical (002432.SZ) issued an announcement. As of April 18, 2024, the company has approved share repurchases...
Jiu'an Medical (002432.SZ): 4.47% of shares have been cumulatively repurchased
Gelonghui, April 12, 丨 Jiu'an Medical (002432.SZ) announced that as of April 12, 2024, the company had repurchased a total of 21,853,761 shares through a special stock repurchase securities account, accounting for 4.47% of the company's total share capital. The highest transaction price was 41.277 yuan/share, the minimum transaction price was 39.42 yuan/share, and the total payment amount was RMB 882,786,470.21 (excluding transaction fees).
Jiu'an Medical (002432.SZ): A total of 3.96% of shares have been repurchased
Gelonghui, April 1, 丨 Jiu'an Medical (002432.SZ) announced that as of March 31, 2024, the company had repurchased a total of 19,376,561 shares through a special stock repurchase securities account, accounting for 3.96% of the company's total share capital. The highest transaction price was 41.277 yuan/share, the minimum transaction price was 39.42 yuan/share, and the total payment amount was RMB 783 million (not including transaction fees).
Subsidiary signs investment agreement with Dark Side of the Moon for 25 billion Kimi Concept Shares issued a change announcement|Highlights of post-market announcements
Zhongtai Chemical: The Securities Regulatory Commission decided to file a case against the controlling shareholder Zhongtai Group due to suspected illegal information disclosure
Express News | Jiu'an Medical: Subsidiary Jiu'an Hong Kong signs investment-related agreements with entities related to Dark Side of the Moon
Jiu'an Medical (002432.SZ): 3.08% of shares have been repurchased cumulatively
Gelonghui, March 7, 丨 Jiu'an Medical (002432.SZ) announced that as of March 7, 2024, the company had repurchased a total of 15,056,236 shares through a special stock repurchase securities account, accounting for 3.08% of the company's total share capital. The highest transaction price was 41.277 yuan/share, the minimum transaction price was 39.42 yuan/share, and the total payment amount was RMB 607 million (excluding transaction fees).
Jiu'an Medical (002432.SZ): The number of shareholders as of the end of February 2024 is approximately 92,000
Gelonghui March 5 | Jiu'an Medical (002432.SZ) said on the investor interactive platform that the number of shareholders as of the end of February 2024 was about 92,000.
Jiu'an Medical (002432.SZ): A total cost of 431 million yuan to buy back 2.20% of the shares
Gelonghui, March 4, 丨 Jiu'an Medical (002432.SZ) announced that as of February 29, 2024, the company had repurchased a total of 10,761,400 shares through a special stock repurchase securities account, accounting for 2.20% of the company's total share capital. The highest transaction price was 40.79 yuan/share, the minimum transaction price was 39.42 yuan/share, and the total payment amount was RMB 431 million (excluding transaction fees).
Jiu'an Medical (002432.SZ) has repurchased 2.04% of its shares at a cost of 401 million yuan
Jiu'an Medical (002432.SZ) announced that as of February 23, 2024, the company is using centralized bidding transactions...
Jiu'an Medical (002432.SZ): 1.13% of shares have been repurchased cumulatively
Gelonghui, Feb. 19 | Jiu'an Medical (002432.SZ) announced that as of February 19, 2024, the company had repurchased 5,502,200 shares through a special stock repurchase securities account, accounting for 1.13% of the company's total share capital. The highest transaction price was 40.79 yuan/share, the minimum transaction price was 39.42 yuan/share, and the total payment amount was RMB 221 million (excluding transaction fees).
Analysis
Price Target
No Data
